Search results

The Americans' Changing Lives (ACL) survey series is an ongoing, nationally representative, longitudinal study focusing especially on differences between Black and White Americans in middle and late life. These data constitute the first, second, third, fourth, fifth, and sixth waves in a panel survey covering a wide range of sociological, psychological, mental, and physical health items. Wave I of the study began in 1986 with a nation face-to-face survey of 3,617 adults ages 25 and up, with Black Americans and people aged 60 and over over-sampled at twice the rate of the others. Wave II constitutes face-to-face re-interviews in 1989 of those still alive. Survivors have been re-interviewed by telephone, and when necessary face-to-face, in 1994 (Wave III), 2001/02 (Wave IV), 2011 (Wave V), and 2019/21 (Wave VI).

Please note that for Wave VI, the majority of data collection occurred in 2019, with only a small subset (n=39) of participants surveyed in 2021.

ACL was designed and sought to investigate the following: (1) The ways in which a wide range of activities and social relationships that people engage in are broadly "productive," (2) how individuals adapt to acute life events and chronic stresses that threaten the maintenance of health, effective functioning, and productive activity, and (3) sociocultural variations in the nature, meaning, determinants, and consequences of productive activity and relationships. Among the topics covered are interpersonal relationships (spouse/partner, children, parents, friends), sources and levels of satisfaction, social interactions and leisure activities, traumatic life events (physical assault, serious illness, divorce, death of a loved one, financial or legal problems), perceptions of retirement, health behaviors (smoking, alcohol consumption, overweight, rest), and utilization of health care services (doctor visits, hospitalization, nursing home institutionalization, bed days). Also included are measures of physical health, psychological well-being, and indices referring to cognitive functioning.

Demographic information provided for individuals includes household composition, number of children and grandchildren, employment status, occupation and work history, income, family financial situation, religious beliefs and practices, ethnicity, race, education, sex, and region of residence.

The Community Vulnerability and Responses to Drug-User-Related HIV/AIDS, 1990-2013 [96 Metropolitan Statistical Areas, United States] study (CVAR) was a research study of why large United States Metropolitan Statistical Areas (MSAs) vary over time in their vulnerability to HIV/AIDS among drug users and in MSA responses to HIV/AIDS. This collection contains estimates of HIV prevalence among people who injected drugs (PWID) and among sub-populations of PWID. This collection is comprised of ten datasets with differing amounts of variables and provides trend data that describe the following:

• Epidemiologic outcomes including population prevalence of PWIDs and Non-injecting drug users (NIDUs), and particularly their prevalence among youth; and, among PWIDs, HIV prevalence, late-diagnosis HIV cases, and AIDS incidence and mortality.
• Implementation of evidence-based drug-related interventions including drug abuse treatment, syringe exchange, HIV counseling and testing.
• Implementation of non-evidence-based drug-related interventions including incarceration and arrests of drug users.

The collection contains data on the MSA sub-populations including Black, Hispanic, White and "other" race categories. In addition, some statistics are presented in age range categories such as ages 15-29, 30-64 and 15-64.

This data collection is comprised of responses from two sets of survey questionnaires, the basic Current Population Survey (CPS) and a survey administered as a supplement to the August 2006 basic CPS questionnaire on the topic of tobacco use in the United States. The Tobacco Use Supplement (TUS), sponsored by the National Cancer Institute and the Centers for Disease Control and Prevention, was also administered in May 2006 (ICPSR 24781) and January 2007 (ICPSR 24783). These three supplements comprise the 2006-2007 waves of TUS data.

The basic CPS, administered monthly, collects labor force data about the civilian noninstitutional population living in the United States. Moreover, the CPS provides current estimates of the economic status and activities of this population which includes estimates of total employment (both farm and nonfarm), nonfarm self-employed persons, domestics, and unpaid helpers in nonfarm family enterprises, wage and salaried employees, and estimates of total unemployment. Data from the CPS are provided for the week prior to the administration of the survey.

The TUS, like most CPS supplements, was designed to be a proxy response supplement, meaning a single respondent could provide answers for all eligible household members, provided the respondent was a household member 15 years of age or older. Unique to the TUS design were also a set of self-respondent supplement questions. All household members age 15 years and older who had completed the basic CPS core items were eligible for the August 2006 supplement items. Beginning in August 2006, 15-17 year old respondents were phased out of the TUS and they were entirely omitted from the January 2007 sample due to Census Bureau budget constraints.

The TUS consisted of items PEA1 through SINTTP. Self-respondents were eligible for the entire supplement, whereas proxy respondents were only eligible for certain items. Information was collected from proxies on topics such as smoking status (items PEA1-PEA3) and the use of other tobacco-related products, such as pipes, cigars, chewing tobacco, and snuff (items PEAJ1A1-PEAJ1A4 and PEJ2A1-PEJSA4).

In addition to these smoking and other tobacco use status questions, self-respondents were queried on the following topics depending on their smoking/tobacco use status (i.e., every day, some days, or former cigarette smokers and/or users of other non-cigarette tobacco products):

• Smoking history

• Current cigarette smoking prevalence and consumption

• Type of cigarettes smoked

• Price of last pack/carton of cigarettes purchased and state of purchase

• Medical and dental advice to quit smoking

• Attempts and intentions to quit smoking cigarettes and/or other forms of tobacco use

• Awareness of 1-800-QUIT-NOW

• Workplace smoking policies and smoking rules in the home

• Attitudes toward smoking in public places

Another generally unique feature to the 2006-2007 TUS-CPS was the administration of questions to former smokers on their previous level of addiction, use of quitlines, and advice from health professionals. This feature enables comparisons between characteristics of former smokers (or successful quitters) and current smokers attempting to quit.

Demographic information collected include age, sex, race, Hispanic origin, marital status, veteran status, educational attainment, family relationship, occupation, and income.

This data collection is comprised of responses from two sets of survey questionnaires, the basic Current Population Survey (CPS) and a survey administered as a supplement to the February 2002 questionnaire on the topic of tobacco use in the United States. The Tobacco Use Supplement (TUS), sponsored by the National Cancer Institute and the Centers for Disease Control and Prevention, was also administered in June 2001 (ICPSR 4043) and November 2001 (ICPSR 4044). These three supplements comprise the 2001-2002 waves of TUS data.

The basic CPS, administered monthly, collects labor force data about the civilian noninstitutional population living in the United States. Moreover, the CPS provides current estimates of the economic status and activities of this population which includes estimates of total employment (both farm and nonfarm), nonfarm self-employed persons, domestics, and unpaid helpers in nonfarm family enterprises, wage and salaried employees, and estimates of total unemployment. Data from the CPS are provided for the week prior to the administration of the survey.

All household members age 15 years and older who had completed the basic CPS monthly items were eligible for the TUS, which consisted of items PES32 through PES77. The TUS was mainly designed to be a proxy response survey, meaning a single respondent could provide answers for all eligible household members. Unique to the TUS design were also a set of self-respondent questions. Self-respondents were eligible for the entire supplement, whereas proxy respondents were only eligible for questions on the topics of smoking status (items PES32-PES34) and the use of other tobacco products; for example, pipes, cigars, chewing tobacco, and snuff (items PES62A-PES63B).

Additionally, self-respondents were asked various questions depending on their smoking status -- former, everyday, or occasional (items PES36-PES46 and PES55-PES61). Current everyday and occasional smokers were then asked whether the medical community had advised them to quit smoking or if they were planning to quit in the near future (items PES47-PES54). Self-respondents were further queried on smoking policies in their work place (items PES67-PES71), smoking rules in the home (item PES73) and questions on opinions about smoking (items PES72, PES75-PES77).

Administrative information was collected on who the proxy respondents were, the language in which the interview was conducted, and the survey method (telephone vs. personal-visit interviews; Computer Assisted Telephone Interviewing (CATI) vs. Computer Assisted Personal Interviewing (CAPI)). Demographic information collected includes age, sex, race, Hispanic origin, marital status, veteran status, educational attainment, family relationship, occupation, and income.

This data collection is comprised of responses from two sets of survey questionnaires, the basic Current Population Survey (CPS) and a survey administered as a supplement to the February 2003 questionnaire on the topic of tobacco use in the United States. The Tobacco Use Supplement (TUS), sponsored by the National Cancer Institute and the Centers for Disease Control and Prevention, was also administered in June 2003 (ICPSR 4527) and November 2003 (ICPSR 4528). These three supplements comprise the 2003 wave of TUS data.

The basic CPS, administered monthly, collects labor force data about the civilian noninstitutional population living in the United States. Moreover, the CPS provides current estimates of the economic status and activities of this population which includes estimates of total employment (both farm and nonfarm), nonfarm self-employed persons, domestics, and unpaid helpers in nonfarm family enterprises, wage and salaried employees, and estimates of total unemployment. Data from the CPS are provided for the week prior to the administration of the survey.

The TUS, like most CPS supplements, was designed to be a proxy response supplement, meaning a single respondent could provide answers for all eligible household members, provided the respondent was a household member 15 years of age or older. Unique to the TUS design were also a set of self-respondent supplement questions. All household members age 15 years and older who had completed the basic CPS core items were eligible for the February 2003 supplement items.

The TUS consisted of items PEA1 through PEK5. Self-respondents were eligible for the entire supplement, whereas proxy respondents were only eligible for certain items. Information was collected from proxies on topics such as smoking status (items PEA1-PEA3) and the use of other tobacco-related products, such as pipes, cigars, chewing tobacco, and snuff (items PEJ1a -PEJ2a).

In addition to these smoking status and other tobacco use questions, self-respondents were queried on the following topics depending on their smoking/tobacco use status (i.e., every day, some days, or former cigarette smokers and/or users of other non-cigarette tobacco products):

• Smoking history

• Current cigarette smoking prevalence and consumption

• Type of cigarettes smoked

• Price of last pack/carton of cigarettes purchased and state where purchased

• Medical and dental advice to quit smoking

• Attempts and intentions to quit smoking cigarettes and/or other forms of tobacco use

• Workplace smoking policies and smoking rules in the home

• Attitudes toward smoking in public places

Another generally unique feature to the 2003 TUS-CPS was the administration of questions to former smokers on their previous level of addiction, products/resources/methods used to quit smoking, and advice from health professionals. This feature enables comparisons between characteristics of former smokers (or successful quitters) and current smokers attempting to quit.

Administrative information was collected on who the proxy respondents were, the language in which the interview was conducted, and the survey method (telephone vs. personal-visit interviews; Computer Assisted Telephone Interviewing (CATI) vs. Computer Assisted Personal Interviewing (CAPI)). Demographic information collected include age, sex, race, Hispanic origin, marital status, veteran status, educational attainment, family relationship, occupation, and income.

This data collection is comprised of responses from two sets of survey questionnaires, the basic Current Population Survey (CPS) and a survey administered as a supplement to the January 2007 basic CPS questionnaire on the topic of tobacco use in the United States. The Tobacco Use Supplement (TUS), sponsored by the National Cancer Institute and the Centers for Disease Control and Prevention, was also administered in May 2006 (ICPSR 24781) and August 2006 (ICPSR 24782). These three supplements comprise the 2006-2007 waves of TUS data.

The basic CPS, administered monthly, collects labor force data about the civilian noninstitutional population living in the United States. Moreover, the CPS provides current estimates of the economic status and activities of this population which includes estimates of total employment (both farm and nonfarm), nonfarm self-employed persons, domestics, and unpaid helpers in nonfarm family enterprises, wage and salaried employees, and estimates of total unemployment. Data from the CPS are provided for the week prior to the administration of the survey.

The TUS, like most CPS supplements, was designed to be a proxy response supplement, meaning a single respondent could provide answers for all eligible household members, provided the respondent was a household member 15 years of age or older. Unique to the TUS design were also a set of self-respondent supplement questions. All household members age 18 years and older who had completed the basic CPS core items were eligible for the January 2007 supplement items. Beginning in August 2006, 15-17 year old respondents were phased out of the TUS and they were entirely omitted from the January 2007 sample due to Census Bureau budget constraints (but remained for the May and August 2006 waves).

The TUS consisted of items PEA1 through SINTTP. Self-respondents were eligible for the entire supplement, whereas proxy respondents were only eligible for certain items. Information was collected from proxies on topics such as smoking status (items PEA1-PEA3) and the use of other tobacco-related products, such as pipes, cigars, chewing tobacco, and snuff (items PEAJ1A1-PEAJ1A4 and PEJ2A1-PEJSA4).

In addition to these smoking and other tobacco use status questions, self-respondents were queried on the following topics depending on their smoking/tobacco use status (i.e., every day, some days, or former cigarette smokers and/or users of other non-cigarette tobacco products):

• Smoking history

• Current cigarette smoking prevalence and consumption

• Type of cigarettes smoked

• Price of last pack/carton of cigarettes purchased and state of purchase

• Medical and dental advice to quit smoking

• Attempts and intentions to quit smoking cigarettes and/or other forms of tobacco use

• Awareness of 1-800-QUIT-NOW

• Workplace smoking policies and smoking rules in the home

• Attitudes toward smoking in public places

Another generally unique feature to the 2006-2007 TUS-CPS was the administration of questions to former smokers on their previous level of addiction, use of quitlines, and advice from health professionals. This feature enables comparisons between characteristics of former smokers (or successful quitters) and current smokers attempting to quit.

Demographic information collected include age, sex, race, Hispanic origin, marital status, veteran status, educational attainment, family relationship, occupation, and income.

This data collection is comprised of responses from two sets of survey questionnaires, the basic Current Population Survey (CPS) and a survey administered as a supplement to the June 2001 questionnaire on the topic of tobacco use in the United States. The Tobacco Use Supplement (TUS), sponsored by the National Cancer Institute and the Centers for Disease Control and Prevention, was also administered in November 2001 (ICPSR 4044) and February 2002 (ICPSR 4031). These three supplements comprise the 2001-2002 waves of TUS data.

The basic CPS, administered monthly, collects labor force data about the civilian noninstitutional population living in the United States. Moreover, the CPS provides current estimates of the economic status and activities of this population which includes estimates of total employment (both farm and nonfarm), nonfarm self-employed persons, domestics, and unpaid helpers in nonfarm family enterprises, wage and salaried employees, and estimates of total unemployment. Data from the CPS are provided for the week prior to the administration of the survey.

All household members age 15 years and older who had completed the basic CPS monthly items were eligible for the TUS, which consisted of items PES32 through PES77. The TUS was mainly designed to be a proxy response survey, meaning a single respondent could provide answers for all eligible household members. Unique to the TUS design were also a set of self-respondent questions. Self-respondents were eligible for the entire supplement, whereas proxy respondents were only eligible for questions on the topics of smoking status (items PES32-PES34) and the use of other tobacco products; for example, pipes, cigars, chewing tobacco, and snuff (items PES62A-PES63B).

Additionally, self-respondents were asked various questions depending on their smoking status -- former, everyday, or occasional (items PES36-PES46 and PES55-PES61). Current everyday and occasional smokers were then asked whether the medical community had advised them to quit smoking or if they were planning to quit in the near future (items PES47-PES54). Self-respondents were further queried on smoking policies in their work place (items PES67-PES71), smoking rules in the home (item PES73) and questions on opinions about smoking (items PES72, PES75-PES77).

Administrative information was collected on who the proxy respondents were, the language in which the interview was conducted, and the survey method (telephone vs. personal-visit interviews; Computer Assisted Telephone Interviewing (CATI) vs. Computer Assisted Personal Interviewing (CAPI)). Demographic information collected includes age, sex, race, Hispanic origin, marital status, veteran status, educational attainment, family relationship, occupation, and income.

This data collection is comprised of responses from two sets of survey questionnaires, the basic Current Population Survey (CPS) and a survey administered as a supplement to the June 2003 questionnaire on the topic of tobacco use in the United States. The Tobacco Use Supplement (TUS), sponsored by the National Cancer Institute and the Centers for Disease Control and Prevention, was also administered in February 2003 (ICPSR 4526) and November 2003 (ICPSR 4528). These three supplements comprise the 2003 wave of TUS data.

The basic CPS, administered monthly, collects labor force data about the civilian noninstitutional population living in the United States. Moreover, the CPS provides current estimates of the economic status and activities of this population which includes estimates of total employment (both farm and nonfarm), nonfarm self-employed persons, domestics, and unpaid helpers in nonfarm family enterprises, wage and salaried employees, and estimates of total unemployment. Data from the CPS are provided for the week prior to the administration of the survey.

The TUS, like most CPS supplements, was designed to be a proxy response supplement, meaning a single respondent could provide answers for all eligible household members, provided the respondent was a household member 15 years of age or older. Unique to the TUS design were also a set of self-respondent supplement questions. All household members age 15 years and older who had completed the basic CPS core items were eligible for the June 2003 supplement items.

The TUS consisted of items PEA1 through PEK5. Self-respondents were eligible for the entire supplement, whereas proxy respondents were only eligible for certain items. Information was collected from proxies on topics such as smoking status (items PEA1-PEA3) and the use of other tobacco-related products, such as pipes, cigars, chewing tobacco, and snuff (items PEJ1a -PEJ2a).

In addition to these smoking status and other tobacco use questions, self-respondents were queried on the following topics depending on their smoking/tobacco use status (i.e., every day, some days, or former cigarette smokers and/or users of other non-cigarette tobacco products):

• Smoking history

• Current cigarette smoking prevalence and consumption

• Type of cigarettes smoked

• Price of last pack/carton of cigarettes purchased and state where purchased

• Medical and dental advice to quit smoking

• Attempts and intentions to quit smoking cigarettes and/or other forms of tobacco use

• Workplace smoking policies and smoking rules in the home

• Attitudes toward smoking in public places

Another generally unique feature to the 2003 TUS-CPS was the administration of questions to former smokers on their previous level of addiction, products/resources/methods used to quit smoking, and advice from health professionals. This feature enables comparisons between characteristics of former smokers (or successful quitters) and current smokers attempting to quit.

Administrative information was collected on who the proxy respondents were, the language in which the interview was conducted, and the survey method (telephone vs. personal-visit interviews; Computer Assisted Telephone Interviewing (CATI) vs. Computer Assisted Personal Interviewing (CAPI)). Demographic information collected include age, sex, race, Hispanic origin, marital status, veteran status, educational attainment, family relationship, occupation, and income.

This data collection is comprised of responses from two sets of survey questionnaires, the basic Current Population Survey (CPS) and a survey administered as a supplement to the May 2006 questionnaire on the topic of tobacco use in the United States. The Tobacco Use Supplement (TUS), sponsored by the National Cancer Institute and the Centers for Disease Control and Prevention, was also administered in August 2006 (ICPSR 24782) and January 2007 (ICPSR 24783). These three supplements comprise the 2006-2007 waves of TUS data.

The basic CPS, administered monthly, collects labor force data about the civilian noninstitutional population living in the United States. Moreover, the CPS provides current estimates of the economic status and activities of this population which includes estimates of total employment (both farm and nonfarm), nonfarm self-employed persons, domestics, and unpaid helpers in nonfarm family enterprises, wage and salaried employees, and estimates of total unemployment. Data from the CPS are provided for the week prior to the administration of the survey.

The TUS -- like most CPS supplements -- was designed to be a proxy response supplement, meaning a single respondent could provide answers for all eligible household members, provided the respondent was a household member 15 years of age or older. Unique to the TUS design were also a set of self-respondent supplement questions. All household members age 15 years and older who had completed the basic CPS core items were eligible for the May 2006 supplement items. Beginning in August 2006, 15-17 year old respondents were phased out of the TUS and they were entirely omitted from the January 2007 sample due to Census Bureau budget constraints.

The TUS consisted of items PEA1 through SINTTP. Self-respondents were eligible for the entire supplement, whereas proxy respondents were only eligible for certain items. Information was collected from proxies on topics such as smoking status (items PEA1-PEA3) and the use of other tobacco-related products, such as pipes, cigars, chewing tobacco, and snuff (items PEAJ1A1-PEAJ1A4 and PEJ2A1-PEJSA4).

In addition to these smoking and other tobacco use status questions, self-respondents were queried on the following topics depending on their smoking/tobacco use status (i.e., every day, some days, or former cigarette smokers and/or users of other non-cigarette tobacco products):

• Smoking history

• Current cigarette smoking prevalence and consumption

• Type of cigarettes smoked

• Price of last pack/carton of cigarettes purchased and state of purchase

• Medical and dental advice to quit smoking

• Attempts and intentions to quit smoking cigarettes and/or other forms of tobacco use

• Awareness of 1-800-QUIT-NOW

• Workplace smoking policies and smoking rules in the home

• Attitudes toward smoking in public places

Another generally unique feature to the 2006-2007 TUS-CPS was the administration of questions to former smokers on their previous level of addiction, use of quitlines, and advice from health professionals. This feature enables comparisons between characteristics of former smokers (or successful quitters) and current smokers attempting to quit.

Demographic information collected include age, sex, race, Hispanic origin, marital status, veteran status, educational attainment, family relationship, occupation, and income.

This data collection is comprised of responses from two sets of survey questionnaires, the basic Current Population Survey (CPS) and a survey administered as a supplement to the November 2001 questionnaire on the topic of tobacco use in the United States. The Tobacco Use Supplement (TUS), sponsored by the National Cancer Institute and the Centers for Disease Control and Prevention, was also administered in June 2001 (ICPSR 4043) and February 2002 (ICPSR 4031). These three supplements comprise the 2001-2002 waves of TUS data.

The basic CPS, administered monthly, collects labor force data about the civilian noninstitutional population living in the United States. Moreover, the CPS provides current estimates of the economic status and activities of this population which includes estimates of total employment (both farm and nonfarm), nonfarm self-employed persons, domestics, and unpaid helpers in nonfarm family enterprises, wage and salaried employees, and estimates of total unemployment. Data from the CPS are provided for the week prior to the administration of the survey.

All household members age 15 years and older who had completed the basic CPS monthly items were eligible for the TUS, which consisted of items PES32 through PES77. The TUS was mainly designed to be a proxy response survey, meaning a single respondent could provide answers for all eligible household members. Unique to the TUS design were also a set of self-respondent questions. Self-respondents were eligible for the entire supplement, whereas proxy respondents were only eligible for questions on the topics of smoking status (items PES32-PES34) and the use of other tobacco products; for example, pipes, cigars, chewing tobacco, and snuff (items PES62A-PES63B).

Additionally, self-respondents were asked various questions depending on their smoking status -- former, everyday, or occasional (items PES36-PES46 and PES55-PES61). Current everyday and occasional smokers were then asked whether the medical community had advised them to quit smoking or if they were planning to quit in the near future (items PES47-PES54). Self-respondents were further queried on smoking policies in their work place (items PES67-PES71), smoking rules in the home (item PES73) and questions on opinions about smoking (items PES72, PES75-PES77).

Administrative information was collected on who the proxy respondents were, the language in which the interview was conducted, and the survey method (telephone vs. personal-visit interviews; Computer Assisted Telephone Interviewing (CATI) vs. Computer Assisted Personal Interviewing (CAPI)). Demographic information collected includes age, sex, race, Hispanic origin, marital status, veteran status, educational attainment, family relationship, occupation, and income.

This data collection is comprised of responses from two sets of survey questionnaires, the basic Current Population Survey (CPS) and a survey administered as a supplement to the November 2003 questionnaire on the topic of tobacco use in the United States. The Tobacco Use Supplement (TUS), sponsored by the National Cancer Institute and the Centers for Disease Control and Prevention, was also administered in February 2003 (ICPSR 4526) and June 2003 (ICPSR 4527). These three supplements comprise the 2003 wave of TUS data.

The basic CPS, administered monthly, collects labor force data about the civilian noninstitutional population living in the United States. Moreover, the CPS provides current estimates of the economic status and activities of this population which includes estimates of total employment (both farm and nonfarm), nonfarm self-employed persons, domestics, and unpaid helpers in nonfarm family enterprises, wage and salaried employees, and estimates of total unemployment. Data from the CPS are provided for the week prior to the administration of the survey.

The TUS, like most CPS supplements, was designed to be a proxy response supplement, meaning a single respondent could provide answers for all eligible household members, provided the respondent was a household member 15 years of age or older. Unique to the TUS design were also a set of self-respondent supplement questions. All household members age 15 years and older who had completed the basic CPS core items were eligible for the November 2003 supplement items.

The TUS consisted of items PEA1 through PEK5. Self-respondents were eligible for the entire supplement, whereas proxy respondents were only eligible for certain items. Information was collected from proxies on topics such as smoking status (items PEA1-PEA3) and the use of other tobacco-related products, such as pipes, cigars, chewing tobacco, and snuff (items PEJ1a-PEJ2a).

In addition to these smoking status and other tobacco use questions, self-respondents were queried on the following topics depending on their smoking/tobacco use status (i.e., every day, some days, or former cigarette smokers and/or users of other non-cigarette tobacco products):

• Smoking history

• Current cigarette smoking prevalence and consumption

• Type of cigarettes smoked

• Price of last pack/carton of cigarettes purchased and state where purchased

• Medical and dental advice to quit smoking

• Attempts and intentions to quit smoking cigarettes and/or other forms of tobacco use

• Workplace smoking policies and smoking rules in the home

• Attitudes toward smoking in public places

Another generally unique feature to the 2003 TUS-CPS was the administration of questions to former smokers on their previous level of addiction, products/resources/methods used to quit smoking, and advice from health professionals. This feature enables comparisons between characteristics of former smokers (or successful quitters) and current smokers attempting to quit.

Administrative information was collected on who the proxy respondents were, the language in which the interview was conducted, and the survey method (telephone vs. personal-visit interviews; Computer Assisted Telephone Interviewing (CATI) vs. Computer Assisted Personal Interviewing (CAPI)). Demographic information collected include age, sex, race, Hispanic origin, marital status, veteran status, educational attainment, family relationship, occupation, and income.

The Detroit Neighborhood Health Study (DNHS) is a prospective, representative longitudinal cohort study of predominantly African American adults living in Detroit, Michigan. The main purpose of the study was to determine the predictive effects of ecological stressors, such as income distribution and residential segregation, on the development of post-traumatic stress disorder (PTSD), substance use, and other psychological and behavioral outcomes. An additional purpose was to study the interrelationships between ecological stressors, exposure to potentially traumatic events (PTEs), PTSD, substance use, and immune function. The study team hypothesized that exposure to ecological stressors would influence the risk of PTE exposure, PTSD, substance use, other psychological outcomes, and the relationships between these factors.

The current collection includes data from all 5 waves of the study. Cohort participants were initially recruited in 2008 with a dual-frame probability design, using telephone numbers obtained from the U.S. Postal Service Delivery Sequence Files as well as a listed-assisted random-digit-dial frame. Individuals without listed landlines or telephones and individuals with only a cell phone listed were invited to participate through a postal mail effort. Participants completed a 40 minute, structured telephone interview annually between 2008-2012 to assess perceptions of participants' neighborhoods, mental and physical health status, social support, exposure to traumatic events, and alcohol and tobacco use. In addition, the study team completed a structured assessment of Detroit's 54 neighborhoods in order to describe the characteristics of respondents' neighborhoods. The assessment included information about the quality of housing exteriors; presence of graffiti, abandoned cars, alcohol and tobacco advertisements, and security warning signs; presence of vacant buildings; and street and traffic noise levels.

All survey participants were offered the opportunity to provide a blood specimen (venipuncture, blood spot, or saliva) for immune and inflammatory marker testing as well as genetic testing of DNA. Participants received an additional $25USD if they elected to give a sample. Informed consent was obtained at the beginning of each interview and again at specimen collection. However, these specimens are not included as part of this data collection.

For more information about the study, please visit the Detroit Neighborhood Health Study website.

Genotypic data from DNHS are available on the NIH database of Genotypes and Phenotypes (dbGaP).

Drug-Abuse Treatment Outcomes Study (DATOS) is a prospective study designed to determine the outcomes of adult drug abuse treatment delivered in typical, stable, community-based programs and to provide comprehensive information on continuing and new questions about the effectiveness of drug abuse treatment for adults currently available in a variety of publicly funded and private programs. The study examined the role of treatment outcomes and program type, client characteristics (including dependence, treatment history, and physical and mental health comorbidities), treatment received (e.g., length and intensity of services provided), therapeutic approaches, provision of aftercare, and research on the components of effective treatment, including factors that engage and retain clients in programs. Four types of programs were included: outpatient methadone (OPM), short-term inpatient (STI), long-term residential (LTR), and outpatient drug-free (ODF). Respondents were sampled from among adults admitted to drug abuse treatment programs in 11 representative U.S. cities during 1991-1993.

Clients entering treatment completed two comprehensive intake interviews (Intake 1 and Intake 2), approximately one week apart. This information is provided in Parts 1 and 2 of the data collection. These interviews were designed to obtain baseline data on drug use and other behaviors, as well as information on background and demographic characteristics, patterns of dependence, living situation and child custody status, education and training, income and expenditures, and HIV risk behaviors, along with assessments of dependence, mental health, physical health, and social functioning. Data on criminal justice status and criminal behavior are reported in Part 5, Illegal Activities Data, and are drawn from the Intake 1 interview. Data reflecting during-treatment progress, including service delivery and client satisfaction, were collected in the one-, three-, and six-month in-treatment interviews (Parts 3, 4, and 8). The 12-Month Post-Treatment Follow-Up Interview (Part 6) replicated many of the intake questions and focused on key behaviors in the year following treatment. Part 7 includes variables for time in treatment and interview availability indicators. The 12-Month Follow-Up Urine Result data (Part 9) provide the results from urine sample tests that were given to a sample of subjects at the time of the 12-Month Follow-Up Interview. Urine specimens were tested for eight categories of drugs (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, methaqualone, opiates, and phencyclidine). The drugs covered in the study were alcohol, tobacco, marijuana (hashish, THC), hallucinogens or psychedelics such as LSD, mescaline, and PCP, cocaine (including crack), heroin, narcotics or opiates such as morphine, codeine, Demerol, Dilaudid, and Talwin, downers or depressants such as sedatives, barbiturates, and tranquilizers, amphetamines or other stimulants such as speed or diet pills, and other drugs. Part 10 contains data for 1393 clients who were interviewed 5 years post treatment. This part contains many of the same types of questions asked during previous interviews.

The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.

DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report medications that are unrelated to the visit.

The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit substances, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse of drugs. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.

The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.

DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report medications that are unrelated to the visit.

The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit substances, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse of drugs. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.

The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.

DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report medications that are unrelated to the visit.

The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit substances, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse of drugs. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.

The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.

DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report medications that are unrelated to the visit.

The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit substances, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse of drugs. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.

The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.

DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report medications that are unrelated to the visit.

The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 16 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit substances, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse of drugs. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.

The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.

DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report medications that are unrelated to the visit.

The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit substances, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse of drugs. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.

The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.

DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report medications that are unrelated to the visit.

The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit substances, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse of drugs. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.

The Drug Abuse Warning Network (DAWN) is a nationally representative public health surveillance system that has monitored drug related emergency department (ED) visits to hospitals since the early 1970s. First administered by the Drug Enforcement Administration (DEA) and the National Institute on Drug Abuse (NIDA), the responsibility for DAWN now rests with the Substance Abuse and Mental Health Services Administration's (SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ). Over the years, the exact survey methodology has been adjusted to improve the quality, reliability, and generalizability of the information produced by DAWN. The current approach was first fully implemented in the 2004 data collection year.

DAWN relies on a longitudinal probability sample of hospitals located throughout the United States. To be eligible for selection into the DAWN sample, a hospital must be a non-Federal, short-stay, general surgical and medical hospital located in the United States, with at least one 24-hour ED. DAWN cases are identified by the systematic review of ED medical records in participating hospitals. The unit of analysis is any ED visit involving recent drug use. DAWN captures both ED visits that are directly caused by drugs and those in which drugs are a contributing factor but not the direct cause of the ED visit. The reason a patient used a drug is not part of the criteria for considering a visit to be drug-related. Therefore, all types of drug-related events are included: drug misuse or abuse, accidental drug ingestion, drug-related suicide attempts, malicious drug poisonings, and adverse reactions. DAWN does not report medications that are unrelated to the visit.

The DAWN public-use dataset provides information for all types of drugs, including illegal drugs, prescription drugs, over-the-counter medications, dietary supplements, anesthetic gases, substances that have psychoactive effects when inhaled, alcohol when used in combination with other drugs (all ages), and alcohol alone (only for patients aged 20 or younger). Public-use dataset variables describe and categorize up to 22 drugs contributing to the ED visit, including toxicology confirmation and route of administration. Administrative variables specify the type of case, case disposition, categorized episode time of day, and quarter of year. Metropolitan area is included for represented metropolitan areas. Created variables include the number of unique drugs reported and case-level indicators for alcohol, non-alcohol illicit substances, any pharmaceutical, non-medical use of pharmaceuticals, and all misuse and abuse of drugs. Demographic items include age category, sex, and race/ethnicity. Complex sample design and weighting variables are included to calculate various estimates of drug-related ED visits for the Nation as a whole, as well as for specific metropolitan areas, from the ED visits classified as DAWN cases in the selected hospitals.

These data are part of NACJD's Fast Track Release and are distributed as they were received from the data depositor. The files have been zipped by NACJD for release, but not checked or processed except for the removal of direct identifiers. Users should refer to the accompanying readme file for a brief description of the files available with this collection and consult the investigator(s) if further information is needed.

Teenage adolescent females residing in Baltimore, Maryland who were involved in a relationship with a history of violence were sought after to participate in this research study. Respondents were interviewed and then followed through daily diary entries for several months. The aim of the research was to understand the context regarding teen dating violence (TDV). Prior research on relationship context has not focused on minority populations; therefore, the focus of this project was urban, predominantly African American females.

The available data in this collection includes three SAS (.sas7bdat) files and a single SAS formats file that contains variable and value label information for all three data files. The three data files are:

• final_baseline.sas7bdat (157 cases / 252 variables)
• final_partnergrid.sas7bdat (156 cases / 76 variables)
• hart_final_sas7bdata (7004 cases / 23 variables)

In collaboration with community- and system-based partners, the current study used an experimental design to test the impact of phone outreach from community-based agencies to women exposed to Intimate Partner Violence (IPV) compared to phone referrals provided by system-based unit (i.e., the Victim Assistance Unit of the DPD or the City Attorney's Office) in a racially and ethnically diverse sample of women whose cases have come to the attention of the criminal justice system. The phone outreach was informed by an interdisciplinary team involving both system- and community-based team members. Participants, who were randomly selected to receive outreach or treatment-as-usual, were interviewed at three time points: after an incident of IPV was reported to the police (T1), 6 months after T1, and 12 months after T1. The study addressed three primary roles. First, investigators evaluated the effectiveness of a coordinated, community-based outreach program in improving criminal justice and victim safety and empowerment outcomes for IPV victims using a longitudinal, randomized control design. Second, victim and case characteristics that moderated outcomes were identified. Third, the influence of spatial characteristics on criminal justice outcomes was evaluated.